Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Avatrombopag”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05218226
What this trial is testing

Avatrombopag for Chemotherapy-induced Thrombocytopenia

Who this might be right for
Chemotherapy-induced ThrombocytopeniaAvatrombopag
Institute of Hematology & Blood Diseases Hospital, China 50
Early research (Phase 1)Study completedNCT01759394
What this trial is testing

A Open-label, Three-period, Partial-replicate Design Study to Evaluate the Inter- and Intrasubject Variability of the Avatrombopag To-be-marketed Formulation Administered as Single Doses of 40 mg to Healthy Subjects Receiving a Low-fat Meal

Who this might be right for
Healthy Volunteers
Eisai Inc. 36
Post-approval studies (Phase 4)Study completedNCT04638829
What this trial is testing

Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim

Who this might be right for
Immune Thrombocytopenia
Sobi, Inc. 60
Not applicableStudy completedNCT04609891
What this trial is testing

Avatrombopag on the Treatment of Thrombocytopenia Induced by Chemotherapy of Malignant Tumors

Who this might be right for
Thrombocytopenia
Anhui Provincial Cancer Hospital 74
Testing effectiveness (Phase 2)Looking for participantsNCT06281327
What this trial is testing

Avatrombopag in the Treatment of Pediatric Immune Thrombocytopenia

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 60
Testing effectiveness (Phase 2)UnknownNCT04797182
What this trial is testing

Avatrombopag for the Primary Prevention of Thrombocytopenia Induced by Cytarabine-based Chemotherapy in Patients With Lymphoma

Who this might be right for
ThrombocytopeniaCytarabine Causing Adverse Effects in Therapeutic UseLymphoma
Sun Yat-sen University 46
Early research (Phase 1)Study completedNCT02809768
What this trial is testing

Study to Assess Pharmacokinetic Drug-Drug Interaction Between Avatrombopag When Co-Administered With Fluconazole, Itraconazole, or Rifampin in Healthy Subjects

Who this might be right for
Healthy Participants
Eisai Inc. 48